Pancreatic cancer is characterized by constitutive activation of mitogen-activated protein kinase (MAPK), due to gain-of-function mutations in KRAS or BRAF and loss-of-function of dual specificity phosphatase 6 (DUSP6) [5-7]. The gene discussed is DUSP6; the disease is pancreatic neoplasm.